AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 39 filers reported holding AGILE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $60,000 | -88.0% | 122,000 | -37.2% | 0.00% | -80.0% |
| Q1 2018 | $499,000 | +49.0% | 194,300 | +55.8% | 0.01% | +25.0% |
| Q4 2017 | $335,000 | -39.0% | 124,700 | +1.4% | 0.00% | -33.3% |
| Q3 2017 | $549,000 | +19.9% | 123,000 | +0.8% | 0.01% | 0.0% |
| Q2 2017 | $458,000 | -27.4% | 122,000 | -38.1% | 0.01% | -25.0% |
| Q1 2017 | $631,000 | -4.8% | 197,000 | +69.3% | 0.01% | -11.1% |
| Q4 2016 | $663,000 | -42.5% | 116,334 | -29.6% | 0.01% | -47.1% |
| Q3 2016 | $1,154,000 | +35.0% | 165,334 | +47.2% | 0.02% | +30.8% |
| Q2 2016 | $855,000 | +104.5% | 112,334 | +66.8% | 0.01% | +85.7% |
| Q1 2016 | $418,000 | -36.4% | 67,334 | 0.0% | 0.01% | -41.7% |
| Q4 2015 | $657,000 | +44.7% | 67,334 | 0.0% | 0.01% | +33.3% |
| Q3 2015 | $454,000 | +7.8% | 67,334 | +37.5% | 0.01% | +12.5% |
| Q2 2015 | $421,000 | +343.2% | 48,966 | +375.4% | 0.01% | +300.0% |
| Q1 2015 | $95,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 4,668,763 | $43,278,000 | 14.12% |
| Aisling Capital LLC | 2,983,797 | $27,660,000 | 3.62% |
| INVESTOR AB | 3,510,189 | $32,539,000 | 2.91% |
| Foresite Capital Management II, LLC | 459,266 | $4,257,000 | 2.52% |
| RA Capital Management | 1,458,792 | $13,523,000 | 1.34% |
| Sio Capital Management, LLC | 203,732 | $1,889,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 80,959 | $750,000 | 0.63% |
| Pinnacle Wealth Management Advisory Group, LLC | 49,623 | $460,000 | 0.41% |
| CAXTON CORP | 26,736 | $248,000 | 0.30% |
| Cormorant Asset Management, LP | 182,053 | $1,688,000 | 0.26% |